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1My View 
Stephen Moss 
Rothamsted Research Harpenden, Hertfordshire AL5 2JQ, United Kingdom; 
stephen.moss@bbsrc.ac.uk 
‘‘Quality of science’’ is a term increasingly cited as a key measure of the excellence of 
research projects. The question arises, should the ‘‘quality of science’’ be assessed in a 
different way for ‘‘pure’’ and ‘‘applied’’ science, such as weed research? ‘‘Why should it?’’ 
you might well ask. Surely, good science is good science, regardless of whether you label it 
‘‘pure’’ or ‘‘applied?’’ So, where do you stand on this issue? What are the key criteria, in your 
opinion, for assessing scientific quality? 
Consider the following scenario. To avoid appearing to single out a specific aspect of weed 
research for criticism (which is not my intention), I will use a medical research scenario. A 
government department is funding a research project on antibiotic resistance. The stated 
objective of the research is to produce recommendations for the best use of antibiotics in 
hospitals to minimize problems with resistance. Compare the approaches by two research 
groups, led by Drs. Laurel and Hardy, respectively.
Dr. Laurel’s research group took samples of resistant bacteria from a local hospital, studied 
them very intensively, and characterized them at the molecular level using novel and 
sophisticated techniques. Many of their approaches were highly original, and their research 
was featured in a series of publications in high-impact journals. The results were also 
presented to other research scientists at prestigious international meetings. The research 
showed that the best way to use antibiotics to contain their resistant strain was to rotate the 
three different types available, A, B, and C. 
Dr. Hardy’s group took a different approach. They quickly recognised that numerous different 
strains of resistant bacteria exist, so took samples from 50 hospitals, after developing an 
effective and representative sampling strategy. Their research was not as ‘‘cutting edge’’ as 
Dr. Laurel’s, and largely used established techniques. They published relatively little in 
scientific journals, but placed greater emphasis on ensuring that every doctor and nurse was 
aware of their findings. They achieved this by publishing in medical magazines and 
presenting results at meetings attended by medical practitioners. Their research showed that 
the best antiresistance strategy, overall, was to rotate use of antibiotics A and B, and only 
use C as a last resort. Indeed, they showed, convincingly, that rotating A, B, and C was likely 
to lead to the rapid evolution of resistance to all three groups in many bacterial strains, 
putting patients’ lives at risk. 
So, if you were on a review panel, how would you assess the ‘‘quality of science’’ of Dr. 
Laurel and Dr. Hardy? Surely, on grounds of innovation, originality, and publication record 
(key criteria in most assessment exercises), Dr. Laurel would win hands down. Does this 
seem fair to Dr. Hardy, whose research has the potential to save lives and is far more 
focused on meeting the objective of the sponsors? I think not. However, what if the objective 
of the research had been purely to develop novel methods for studying antibiotic resistance, 
without any requirement for practical recommendations? In this case, Dr. Laurel’s research 
would certainly justify greater recognition for its superior level of innovation. Clearly, any 
assessment of the ‘‘quality of science’’ must take on board the aims and objectives behind 
the research, and these might well differ for ‘‘pure’’ and ‘‘applied’’ research projects. 
2So, what is the critical difference between ‘‘pure’’ and ‘‘applied’’ research? To me, pure 
science can be considered primarily an ‘‘end in itself’’ whereas applied science is a ‘‘means 
to an end.’’ In relation to weed research, that ‘‘end’’ is better practical weed management. I 
should emphasis that I am not suggesting that pure research is irrelevant to weed 
management—that would be foolish indeed. The fact that about 63% of the estimated 114 
million ha sown with GM crops worldwide in 2007 possess herbicide-resistance traits is a 
good example of a practical development in weed management that has its origin in 
fundamental studies on genetic manipulation of plants. 
Cousens (1999), in a very thought-provoking paper, raised the issue of whether one should 
accept a different set of values for judging weed science because it is an ‘‘applied science.’’ 
He also argued that much ‘‘weed science’’ is, in reality, ‘‘weed technology.’’ Those are 
pertinent issues, but I would argue that, when judging the value of any applied research 
project, the critical point is how the outputs relate to the scope of the work, regardless of 
whether it is labelled ‘‘science’’ or ‘‘technology.’’ 
One might argue that ‘‘quality of science’’ is but one of many assessment criteria, and that 
other factors, such as ‘‘public good,’’ should be given equal, or greater, weighting. I agree, 
but believe that, at least in Europe, a disproportionate weighting is given to journal ‘‘impact 
factors’’ and citation indices. In Europe, the ‘‘h’’ index (Hirsch 2005) is growing in popularity 
in many ‘‘quality of science’’ exercises, as it provides a simple measure of the broad impact 
of an individual’s publication record. It is significant that Hirsch’s paper deals almost 
exclusively with the ‘‘impact’’ of publication in the scientific literature. That might be 
appropriate for assessing pure science, but is that really the critical factor for assessing the 
value of applied science, such as weed research, or indeed, the relative merits of Dr. 
Laurel’s and Dr. Hardy’s research in the example above? 
In my opinion, applied research should not be judged by the same criteria as pure research. 
Certainly in the UK, it is easy to find examples of applied research that have been highly 
praised by sponsors, but severely criticized in research assessment exercises as a 
consequence of appraisal using criteria more appropriate for pure research. The motivational 
effects of being patted on the back one day, and proverbially stabbed in the back the next, 
are not good. In relation to weed research, it should never be forgotten that, however great 
the ‘‘impact’’ of a publication or the ‘‘quality of the science,’’ it achieves nothing in terms of 
improving our ability to manage weeds, until the information is used in practice. 
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